scispace - formally typeset
C

Chandan Pal

Researcher at Indian Institute of Technology Guwahati

Publications -  27
Citations -  134

Chandan Pal is an academic researcher from Indian Institute of Technology Guwahati. The author has contributed to research in topics: Markov chain & Saddle point. The author has an hindex of 5, co-authored 21 publications receiving 86 citations. Previous affiliations of Chandan Pal include Indian Institute of Science & Indian Institute of Technology Bombay.

Papers
More filters
Journal ArticleDOI

Risk-Sensitive Control of Pure Jump Process on Countable Space with Near Monotone Cost

TL;DR: In this article, the authors studied risk-sensitive control problem with controlled continuous time pure jump process on a countable space as state dynamics and proved the existence and a characterization of optimal risk sensitive control under the near monotone condition.
Journal ArticleDOI

Risk-Sensitive Ergodic Control of Continuous Time Markov Processes With Denumerable State Space

TL;DR: In this article, the authors prove the existence and a characterization of optimal risk-sensitive control under geometric ergodicity of the state dynamics along with a smallness condition on the running cost.
Journal ArticleDOI

Zero-sum risk-sensitive stochastic games for continuous time Markov chains

TL;DR: In this paper, the authors studied infinite horizon discounted-cost and ergodic-cost risk-sensitive zero-sum stochastic games for controlled continuous time Markov chains on a countable state space.
Journal ArticleDOI

Risk sensitive control of pure jump processes on a general state space

TL;DR: In this paper, a stochastic control problem for pure jump processes on a general state space with risk sensitive discounted and ergodic cost criteria was studied, and the authors proved the existence of the discounted cost criterion.
Journal ArticleDOI

Synthesis of Amide Linked Cyclic Dinucleotide Analogues with Pyrimidine Bases

TL;DR: A convenient protocol has been developed for the synthesis of C2-symmetric cyclic dinucleotide analogs with all pyrimidine bases having amides in place of natural phosphodiester linkages, starting from commercially available D-glucose diacetonide.